Wire Stories

Onto Innovation Expands Customer Collaborations with Investment in Training, Demonstration and Solutions Development Centers in Asia

August 24 opening of center located in Korea to be followed by a center in Taiwan later in the year…

4 years ago

Intelsat Commercial Aviation goes into Agreement with Nelco to Offer Inflight Connectivity in India’s Airspace

Intelsat enters India’s untapped commercial airline market MCLEAN, Va. and MUMBAI, India--(BUSINESS WIRE)--Intelsat, operator of one of the world’s largest…

4 years ago

FIS to Modernize Real-Time Payments Infrastructure and Central Bank Digital Currencies for Countries Around the World

Key facts FIS is now offering a central infrastructure payment solution through RealNet™ Central, which enables countries to modernize or…

4 years ago

Biocytogen Expands Partnership with Merck KGaA, Darmstadt, Germany

BEIJING & DARMSTADT, Germany--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered into a global licensing agreement with Merck KGaA, Darmstadt,…

4 years ago

Nighthawk Gold Completes 2022 Exploration Program Drilling Ahead of Schedule

TORONTO--(BUSINESS WIRE)--$MIMZF #commodities--Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK; OTCQX: MIMZF) is pleased to report the completion of…

4 years ago

Avanci Signs Agreements with Hyundai and Kia

South Korean automakers join Avanci’s essential patent marketplace for connected vehicles DALLAS--(BUSINESS WIRE)--Today, Avanci announced that it has signed patent…

4 years ago

Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome

The 25-week weight loss study which achieved its previously reported primary endpoints also examined the effects of GS200 on insulin…

4 years ago

Grab Reports Second Quarter 2022 Results

Q2 record Revenue of $321 million, up 79% year-over-year Q2 GMV of $5.1 billion, up 30% year-over-year Q2 Loss for…

4 years ago

Genius Group Enters into a Securities Purchase Agreement for US$18.13 Million Private Placement

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group,…

4 years ago

LYNPARZA® (olaparib) Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer

First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint…

4 years ago